Associations of semaglutide with Alzheimers disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study, was published in the Journal of Alzheimers Disease on June 24, 2025.
No room for calculation error
No, small air bubbles in GLP-1 pens pose virtually no health risk because these medications are injected subcutaneously (under the skin), where any air is simply absorbed by surrounding tissue rather than entering the bloodstream
A 2022 study on semaglutide found that participants lost an average of 15% of their body weight over 68 weeks
Ive always had very thick, long hair naturally
The activated GLP-1 receptors trigger the pancreas to release more insulin in response to high blood sugar (after meals) and simultaneously signal the liver to produce less glucagon , a hormone that raises blood sugar